Radiomics in lung diseases imaging: State-of-the-art for clinicians

81Citations
Citations of this article
91Readers
Mendeley users who have this article in their library.

Abstract

Artificial intelligence (AI) has increasingly been serving the field of radiology over the last 50 years. As modern medicine is evolving towards precision medicine, offering personalized patient care and treatment, the requirement for robust imaging biomarkers has gradually increased. Radiomics, a specific method generating high-throughput extraction of a tremendous amount of quantitative imaging data using data-characterization algorithms, has shown great potential in individuating imaging biomarkers. Radiomic analysis can be implemented through the following two methods: hand-crafted radiomic features extraction or deep learning algorithm. Its application in lung diseases can be used in clinical decision support systems, regarding its ability to develop descriptive and predictive models in many respiratory pathologies. The aim of this article is to review the recent literature on the topic, and briefly summarize the interest of radiomics in chest Computed Tomography (CT) and its pertinence in the field of pulmonary diseases, from a clinician’s perspective.

Cite

CITATION STYLE

APA

Frix, A. N., Cousin, F., Refaee, T., Bottari, F., Vaidyanathan, A., Desir, C., … Guiot, J. (2021, July 1). Radiomics in lung diseases imaging: State-of-the-art for clinicians. Journal of Personalized Medicine. MDPI. https://doi.org/10.3390/jpm11070602

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free